Walmart opposes dismissal of amended US generic drug pricing claims
MLex Summary: Walmart has filed an opposition to dismissal of its amended US generic drug price-fixing claims, arguing that multiple separate motions-to-dismiss from pharmaceutical manufacturers are futile given that a federal...To view the full article, register now.
Already a subscriber? Click here to view full article